Clinical Trial Update: Nasally Delivered Pulmozyme for Sinusitis in Cystic Fibrosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a nasally delivered Pulmozyme (dornase alfa) for sinusitis in cystic fibrosis; the study completed and results were posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis
• Sinusitis

Drugs mentioned

• Pulmozyme (dornase alfa)

Snippet

Sponsor: University of Vermont | Conditions: Sinusitis, Cystic Fibrosis | Phase 2 | Status: COMPLETED | Results posted: 2014-11-14